Sign in

CIK 0001177648

  • Non-accelerated filer
  • Smaller reporting company

ENANTA PHARMACEUTICALS INC

Sign in to watch
Ticker
ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Entity type
Operating
EIN
043205099
Phone
+1 617-607-0800
Business address
4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-12 Luly Jay R. President and CEO Grant or award +4,800 862,826
2026-02-12 Luly Jay R. President and CEO Grant or award +15,200 878,026
2026-02-12 Luly Jay R. President and CEO Shares withheld for taxes −6,155 $14.25 $88K 871,871
2025-12-05 Luly Jay R. President and CEO Sale −4,743 $14.23 $67K 858,026
2025-12-01 Luly Jay R. President and CEO Shares withheld for taxes −1,885 $14.12 $27K 862,769
2025-11-25 Luly Jay R. President and CEO Grant or award · Stock Option (right to buy) +310,000 310,000
2025-02-12 Luly Jay R. President and CEO Grant or award +25,500 872,138
2025-02-12 Luly Jay R. President and CEO Shares withheld for taxes −7,484 $5.59 $42K 864,654
2025-02-12 Luly Jay R. President and CEO Purchase +45,000 $5.69 $256K 846,638
2024-12-06 Luly Jay R. President and CEO Sale 10b5-1 −5,142 $8.06 $41K 801,638
2024-12-01 Luly Jay R. President and CEO Shares withheld for taxes −3,829 $8.60 $33K 806,780
2024-11-27 Luly Jay R. President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2024-02-12 Luly Jay R. President and CEO Grant or award +5,400 812,193
2024-02-12 Luly Jay R. President and CEO Shares withheld for taxes −1,584 $12.41 $20K 810,609
2023-12-05 Luly Jay R. President and CEO Sale −7,230 $9.63 $70K 806,793
2023-12-01 Luly Jay R. President and CEO Shares withheld for taxes −5,787 $9.49 $55K 814,023
2023-11-22 Luly Jay R. President and CEO Grant or award · Stock Option (right to buy) +264,000 264,000
2023-03-13 Luly Jay R. President and CEO Option exercise +27,912 $14.00 $391K 847,722
2023-03-13 Luly Jay R. President and CEO Sale −10,697 $44.81 $479K 837,025
2023-03-13 Luly Jay R. President and CEO Sale −15,649 $45.31 $709K 821,376

Page 1 of 3 · 54 trades